Recommendations on multiple testing adjustment in multi-arm trials with a shared control group
暂无分享,去创建一个
Susan Todd | S. Todd | W. Gregory | Julia M. Brown | Julia M Brown | Walter M Gregory | Dena R Howard | D. Howard
[1] P. Westfall,et al. Multiplicity in Clinical Trials , 2018 .
[2] J. Wason,et al. Correcting for multiple-testing in multi-arm trials: is it necessary and is it done? , 2014, Trials.
[3] M. Parmar,et al. More multiarm randomised trials of superiority are needed , 2014, The Lancet.
[4] David Morgan,et al. Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert group , 2013, Pharmaceutical statistics.
[5] Thomas Jaki,et al. Some recommendations for multi-arm multi-stage trials , 2012, Statistical methods in medical research.
[6] A. Stone,et al. Multiplicity adjustments in trials with two correlated comparisons of interest , 2011, Statistical methods in medical research.
[7] Sue-Jane Wang,et al. Challenges to multiple testing in clinical trials , 2010, Biometrical journal. Biometrische Zeitschrift.
[8] R. Gray,et al. Multi-Arm Clinical Trials of New Agents: Some Design Considerations , 2008, Clinical Cancer Research.
[9] 森川 敏彦,et al. COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS ( CPMP ) POINTS TO CONSIDER ON MULTIPLICITY ISSUES IN CLINICAL TRIALS , 2002 .
[10] Michael Hughes,et al. Multiplicity in Clinical Trials , 2005 .
[11] Zhenming Shun,et al. Statistical consideration of the strategy for demonstrating clinical evidence of effectiveness—one larger vs two smaller pivotal studies , 2005 .
[12] S. Lange,et al. Adjusting for multiple testing--when and how? , 2001, Journal of clinical epidemiology.
[13] M A Waclawiw,et al. Practical guidelines for multiplicity adjustment in clinical trials. , 2000, Controlled clinical trials.
[14] Stephen Senn,et al. Statistical Issues in Drug Development , 1997 .
[15] M. Proschan,et al. Multiple comparisons with control in a single experiment versus separate experiments : why do we feel differently ? , 1995 .
[16] D A Follmann,et al. Monitoring pairwise comparisons in multi-armed clinical trials. , 1994, Biometrics.
[17] Charles W. Dunnett,et al. A Step-Up Multiple Test Procedure , 1992 .
[18] K J Rothman,et al. No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.
[19] Y. Hochberg. A sharper Bonferroni procedure for multiple tests of significance , 1988 .
[20] C. Dunnett. A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .
[21] E. Chiorean. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial , 2011 .
[22] H. Abdi. The Bonferonni and Šidák Corrections for Multiple Comparisons , 2006 .
[23] Guidance for Industry Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products , 1998 .
[24] Richard J. Cook,et al. Multiplicity Considerations in the Design and Analysis of Clinical Trials , 1996 .
[25] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .